October 23, 2008
John Key’s announcement today that a National-led government will fund 12 months of Herceptin could bring immeasurable relief to women and their families affected by early stage HER2 positive breast cancer.
10th December 2008
The government’s announcement it will provide funding for 52 weeks of the breast cancer drug Herceptin means Christmas will come early for hundreds of New Zealand women with Her2 positive early breast cancer and their families.
Libby Burgess, chair of the Breast Cancer Aotearoa Coalition says the decision comes as a huge relief for the women of New Zealand.
28 May 2009
The Breast Cancer Aotearoa Coalition (BCAC) applauds the Government’s move to boost funding for healthcare as part of Budget 2009.
The Finance Minister, Bill English, announced today that an additional $3billion would be invested in health over the next four years. This includes new money for subsidised medicines and elective surgery.
12 August 2009
The Breast Cancer Aotearoa Coalition (BCAC) believes new national guidelines on the management of early breast cancer will help to save lives.
The New Zealand Guidelines Group today released the Early Breast Cancer Guidelines at the inaugural National Maori Cancer Forum in Rotorua.
The final TriWoman Series is being held on April 9, 2011 at Pt Chevalier. Give it a go and you'll be supporting BCAC member group, the New Zealand Breast Cancer Foundation (NZBCF).
With a swim of 300m, cycle of approx 10km and a run or walk of approx 3km to finish, the distances are achievable but challenging enough to give a real sense of accomplishment. Sign up for it now!
The Breast Cancer Aotearoa Coalition is thrilled its chairperson, Elisabeth Burgess (Libby), has been recognised in the 2011 New Year’s Honours.
Ms Burgess has become a Member of the New Zealand Order of Merit for her work with women, their families and communities affected by breast cancer.
The Coalition’s deputy chair, Dr Chris Walsh, says the award is well-deserved.
More than 1,700 post-menopausal women who have been treated with hormonal therapy for more than four years are invited to take part in this clinical trial run by the Australia New Zealand Breast Cancer Trials Group (ANZBCTG).
The study examines whether being given the drug Letrozole a year or more after completing hormonal therapy can prevent or delay breast cancer from recurring in postmenopausal women.
Starting shoulder exercises soon after surgery for breast cancer can result in a significant improvement in recovery of movement, according to Australian researchers.
They said upper-limb dysfunction was a common side effect of breast cancer surgery.
The Breast Cancer Aotearoa Coalition is thrilled its chairperson, Elisabeth Burgess (Libby), has been recognised in the 2011 New Year’s Honours.
Ms Burgess has become a Member of the New Zealand Order of Merit for her work with women, their families and communities affected by breast cancer.
The Coalition’s deputy chair, Dr Chris Walsh, says the award is well-deserved.
